Informatics

Drug Discovery Informatics Strategic Business Report 2023-2030: Growing Demand for Efficient Drug Development Processes Drives Growth, Expansion of Genomics and Proteomics Research Spurs Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, September 13, 2024
General Health, Health Technology, Pharmaceutical, Health, Software engineering, Informatics, Service, Collaborative Drug Discovery, Software, Drug discovery

The "Drug Discovery Informatics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Drug Discovery Informatics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Drug Discovery Informatics was estimated at US$2.5 Billion in 2023 and is projected to reach US$4.8 Billion by 2030, growing at a CAGR of 8.4% from 2023 to 2030.
  • This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
  • How is the Global Drug Discovery Informatics Market expected to evolve by 2030?

MIE2024 Conference article shows material data quality improvement and time savings in clinical trial data capture with nCartes

Retrieved on: 
Thursday, September 12, 2024
IOS, EDC, Quality control, Research, Data collection, FHIR, Tradition, University, SWOG, Health informatics, Roger Hawkins (drummer), Electronic health record, Clinical trial, Informatics, Professor, IOS Press, Computer, Conference, QC, Digital health, EHR, Health, Millennium, NCI, DRS, Burroughs Wellcome Fund, Associate, National Cancer Institute, Medicine, MPH, Medical record, Accuracy and precision, CCDM, Open access

FREMONT, Calif., Sept. 12, 2024 /PRNewswire/ -- The 34th Medical Informatics Europe Conference was held in Athens, Greece August 25-29, 2024.

Key Points: 
  • FREMONT, Calif., Sept. 12, 2024 /PRNewswire/ -- The 34th Medical Informatics Europe Conference was held in Athens, Greece August 25-29, 2024.
  • The conference theme was "Digital Health and Informatics Innovations for Sustainable Health Care Systems."
  • At the conference, Maryam Y. Garza, PhD, MPH, MMCi, presented her peer-reviewed article "Comparing the Accuracy of Traditional vs. FHIR®-Based Extraction of Electronic Health Record Data for Two Clinical Trials."
  • Garza and Zozus, their team, and our colleagues at SWOG are a delight to collaborate with," says John S. McIlwain, CEO of nCartes, Inc. "The project shows the significant data quality improvements and staff time savings nCartes can produce."

LabVantage Named Global LIMS Company of the Year by Frost & Sullivan

Retrieved on: 
Thursday, September 12, 2024
Software, Research, Professional Services, Pharmaceutical, Data Management, Technology, Health Technology, Data Analytics, Science, Biotechnology, Consulting, Health, LabVantage, Innovation, Growth, Laboratory, Food, Informatics, Frost, Government, Health care, Artificial intelligence, LIMS, Public expenditure, Software as a service, Multimedia

View the full release here: https://www.businesswire.com/news/home/20240912829381/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240912829381/en/
    The award, part of Frost & Sullivan’s Best Practices Awards series , acknowledges companies that demonstrate excellence in growth and innovation.
  • In the Radar, Frost & Sullivan evaluated 50 LIMS vendors, plotting the top 14 for their advanced capabilities in interoperability, scalability, and configurability.
  • “It is a great honor to be awarded Company of the Year in the Global LIMS industry by an esteemed industry advisory firm such as Frost & Sullivan,” said Mikael Hagstroem, CEO of LabVantage Solutions.
  • For more information on LabVantage and its comprehensive LIMS solutions, visit www.labvantage.com or email [email protected] .

More than 400 Health Care Professionals to Gather in Chicago to Improve Health Care

Retrieved on: 
Tuesday, September 10, 2024
Certification, Medical specialty, Research, University, FRCPC, ABMS, Member, Conference, Informatics, Challenge, Emergency medicine, Organization, Medical education, Health policy, Professional, Credentialing, Nursing

CHICAGO, Sept. 10, 2024 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization that oversees U.S. physician and medical specialist certification, will host ABMS Conference 2024 September 24-26 at the Fairmont Chicago, Millennium Park.

Key Points: 
  • CHICAGO, Sept. 10, 2024 /PRNewswire/ -- The American Board of Medical Specialties (ABMS), the leading not-for-profit organization that oversees U.S. physician and medical specialist certification, will host ABMS Conference 2024 September 24-26 at the Fairmont Chicago, Millennium Park.
  • ABMS Conference 2024 is the premier health care conference on board certification with a focus on assessment, lifelong learning, improvement, and professionalism.
  • During interactive sessions, participants will learn about innovations that support the work that they do, discover trends in certification, and deepen their field of expertise.
  • This annual event attracts a diverse community of health care professionals, including ABMS Member Boards and Associate Members, medical specialty societies, health care credentialing organizations, and others interested in assessment and evaluation, credentialing, data sharing and informatics, health policy and research, medical education, professional regulation, and quality improvement.

Baylor Genetics Named to Fast Company’s Best Workplaces for Innovators List

Retrieved on: 
Tuesday, September 10, 2024
Research, Hospital, DNA, Patient, Baylor University, Automation, Informatics, WGS, Robotics, Health, Baylor College of Medicine, Artificial intelligence, BCM, Genetic testing, Genetics, Pharmaceutical industry

HOUSTON, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic laboratory at the forefront of genetic testing, announced it has been named to Fast Company’s Best Workplaces for Innovators List .

Key Points: 
  • HOUSTON, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Baylor Genetics , a clinical diagnostic laboratory at the forefront of genetic testing, announced it has been named to Fast Company’s Best Workplaces for Innovators List .
  • This recognition underscores Baylor Genetics’ commitment to cultivating internal innovation and forging ahead in the marketplace.
  • For more than 45 years, Baylor Genetics has led the way in genetic testing by empowering patients, providers, and healthcare partners with answers that matter.
  • Under the leadership of Baylor Genetics’ President and Chief Executive Officer, Kengo Takishima, Baylor Genetics is expanding its digital technologies, robotics, and automated workflow tools.

Gregory N. Sossaman, MD, MASCP, Installed as 2024-2025 President of the American Society for Clinical Pathology

Retrieved on: 
Saturday, September 7, 2024
Water, MD, Ochsner Health System, Medical school, Hurricane Katrina, LSU, Pathology, Informatics, Society, School, ASCP, Volunteering, Louisiana State University, Medical laboratory, Dentistry

CHICAGO, Sept. 6, 2024 /PRNewswire-PRWeb/ -- Gregory N. Sossaman, MD, MASCP, was installed today as 2024-2025 President of the American Society for Clinical Pathology (ASCP) during the Society's Annual Meeting, Sept. 3-6, in Chicago, IL. Dr. Sossaman is System Chair of Clinical Pathology and Service Line Leader of the Department of Pathology and Laboratory Medicine at Ochsner Health in New Orleans, LA.

Key Points: 
  • CHICAGO, Sept. 6, 2024 /PRNewswire-PRWeb/ -- Gregory N. Sossaman, MD, MASCP, was installed today as 2024-2025 President of the American Society for Clinical Pathology (ASCP) during the Society's Annual Meeting, Sept. 3-6, in Chicago, IL.
  • Dr. Sossaman is System Chair of Clinical Pathology and Service Line Leader of the Department of Pathology and Laboratory Medicine at Ochsner Health in New Orleans, LA.
  • He completed his internship and residency in anatomic and clinical pathology at LSU Medical Center and served as Chief Resident.
  • His professional practice is primarily in clinical pathology (including pathology informatics) along with leadership and management responsibilities.

Florida Cancer Specialists & Research Institute Leverages Real-World Evidence Capabilities To Advance Blood Cancer Treatment

Retrieved on: 
Friday, September 6, 2024
Real-World Evidence, Pancreatic serous cystadenoma, Research, Bone marrow, MD, Data science, Doctor of Philosophy, Lymphoma, Multiple myeloma, Informatics, Partnership, FACP, Hematology, Patient, Health, Malignancy, FCS, Society, SOHO, Nursing

 FORT MYERS, Fla., Sept. 6, 2024 /PRNewswire/ -- Research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) that draws on its expansive informatics capabilities is being presented among the latest advances in the understanding and treatment of blood cancers and related malignancies at the Society for Hematologic Oncology 2024 annual meeting this week in Houston.   

Key Points: 
  • FORT MYERS, Fla., Sept. 6, 2024 /PRNewswire/ -- Research conducted with participation from Florida Cancer Specialists & Research Institute, LLC (FCS) that draws on its expansive informatics capabilities is being presented among the latest advances in the understanding and treatment of blood cancers and related malignancies at the Society for Hematologic Oncology 2024 annual meeting this week in Houston.
  • FCS President and Managing Physician Lucio N. Gordan, MD said, "FCS has made forward-thinking investments in the development of unique, proprietary datasets.
  • These are now yielding significant insights that are directly informing clinical decisions and improving patient outcomes worldwide."
  • The FCS Real-World Evidence team works with internal and external partners providing insights to improve treatment decisions and clinical outcomes based on evidence generated using real-world data.

RadNet’s DeepHealth and HOPPR Forge Partnership to Advance AI in Healthcare

Retrieved on: 
Thursday, September 5, 2024
Prostate, Radiology, RadNet, AI, Breast, Google Images, Doctor of Philosophy, Partnership, Automation, Fine-tuning, MD, Informatics, Machine learning, Health, Lung cancer, Data collection, OS, Medical imaging

CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- DeepHealth, a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered radiology and health informatics, today announces a data and AI development partnership with HOPPR (www.hoppr.ai).

Key Points: 
  • CAMBRIDGE, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- DeepHealth, a wholly-owned subsidiary of RadNet, Inc. (NASDAQ: RDNT) and a global leader in AI-powered radiology and health informatics, today announces a data and AI development partnership with HOPPR (www.hoppr.ai).
  • HOPPR’s Medical-Grade Generalized Foundation Model enhances medical research and hypotheses while simplifying and lowering costs for data collection and training.
  • “We are pleased to partner with DeepHealth to transform healthcare informatics,” said Khan Siddiqui, MD – Chief Executive Officer of HOPPR.
  • DeepHealth OS supports radiology departments with a comprehensive solution for medical imaging, including operational solutions and end-to-end services across the care continuum.

Sapio Sciences Advances The World's First AI-Powered Lab Assistant

Retrieved on: 
Tuesday, September 3, 2024
Biometrics, Chemicals, Plastics, Science, Artificial Intelligence, Manufacturing, Other Health, Radiology, Other Science, Pharmaceutical, Research, Oncology, Medical Devices, Stem Cells, Health Technology, Practice Management, Nanotechnology, Hospitals, Genetics, General Health, Clinical Trials, Cardiology, Biotechnology, Alternative Medicine, Other Technology, AIDS, Health, Software, Electronic Design Automation, Neurology, Data Management, Technology, Data Analytics, Professional Services, Drug discovery, Human, Data analysis, AI, ELN, LIMS, Integration, Informatics, Typesetting

Sapio Sciences , the science-aware™ lab informatics platform, today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently.

Key Points: 
  • Sapio Sciences , the science-aware™ lab informatics platform, today announced significant enhancements to Sapio ELaiN, the pioneering AI-powered lab assistant that helps scientists streamline processes and work more efficiently.
  • As part of the Sapio Lab Informatics Platform , Sapio ELaiN works seamlessly with Sapio LIMS , Sapio ELN , and Sapio Jarvis to simplify life in the lab, aiding scientists and lab operations in efficiently configuring processes and workflows, improving day-to-day operations, and enhancing data analysis and reporting.
  • Kevin continued: “Achieving this level of AI requires it to be deeply integrated into the Sapio lab informatics platform.
  • Sapio ELaiN is now available as an add-on option to the Sapio Platform.

P-Cure Announces the Appointment of Dr. John Wong to its Scientific Advisory Board Supporting its Innovative Growth Strategy

Retrieved on: 
Tuesday, September 3, 2024
Radiation therapy, University, Beaumont Hospital, Royal Oak, Harold Johns, Research, CBCT, ARC, Protocol, TEL, Johns Hopkins University, Cancer, Proton therapy, Royal college, Active, IGRT, Education, Informatics, Radiation, FDA, Patient, Medical physics, ABC, Medical device

TEL AVIV, Israel, Sept. 3, 2024 /PRNewswire-PRWeb/ -- Dr. John Wong, as a new Board Member, will help P-Cure to incorporate cutting edge scientific advances into the most compact adaptive proton therapy solution for treating cancer patients.

Key Points: 
  • "We are delighted to have Dr. Wong join us as a new member of our Scientific Advisory Board as we move the frontiers of medical physics forward," said Dr. Michael Marash, CEO of P-Cure.
  • P-Cure has developed and provides the most compact FDA-cleared proton therapy solution available in the market.
  • Dr. Wong is an author of over 190 peer-reviewed scientific publications and 20 book chapters.
  • Dr. Wong is a recipient of the George Edelstyn Lecture Medal from the Royal College of Radiology, UK in 2001.